Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review
Open accessThe DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
Cartilage degeneration is a key feature of aging and osteoarthritis, characterized by the progressive deterioration of joint function, pain, and limited mobility. Current treatments focus on symptom relief, not cartilage regeneration. Mesenchymal stromal cells (MSCs) offer a promising therapeutic option due to their capability to differentiate into chondrocytes, modulate inflammation, and promote tissue regeneration. This review explores the potential of MSCs for cartilage regeneration, examining their biological properties, action mechanisms, and applications in preclinical and clinical settings. MSCs derived from bone marrow, adipose tissue, and other sources can self-renew and differentiate into multiple cell types. In aging cartilage, they aid in tissue regeneration by secreting growth factors and cytokines that enhance repair and modulate immune responses. Recent preclinical studies show that MSCs can restore cartilage integrity, reduce inflammation, and improve joint function, although clinical translation remains challenging due to limitations such as cell viability, scalability, and regulatory concerns. Advancements in MSC delivery, including scaffold-based approaches and engineered exosomes, may improve therapeutic effectiveness. Potential risks, such as tumorigenicity and immune rejection, are also discussed, emphasizing the need for optimized treatment protocols and large-scale clinical trials to develop effective, minimally invasive therapies for cartilage regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MSC-based therapies demonstrate superior potential in cartilage repair and osteoarthritis, yet high costs and regulatory barriers hinder clinical adoption [125,126].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [125]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [125]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cross, M., Smith, E., Hoy, D., Nolte, S., Ackerman, I., Fransen, M., Bridgett, L., Williams, S., Guillemin, F., Hill, C. L., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204763 · Cited by 3,496 · cited 1×
“Hip and knee OA are particularly significant, ranking as the 11th highest contributor to global disability in 2010 [4].”
Safiri, S., Kolahi, A.-A., Smith, E., Hill, C., Bettampadi, D., Mansournia, M. A., Hoy, D., Ashrafi-Asgarabad, A., Sepidarkish, M., Almasi-Hashiani, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216515 · Cited by 1,651 · cited 2×
“From 1990 to 2017, the global age-standardized prevalence of OA increased by 9.3% to 3754.2 per 100,000 [2].”
InfluentialChallenges and directions in studying cell–cell communication by extracellular vesicles
van Niel, G., Carter, D. R. F., Clayton, A., Lambert, D. W., Raposo, G., & Vader, P. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00460-3 · Cited by 1,229 · cited 2×
“They show promise as biomarkers, therapeutic agents, and drug delivery vehicles [131].”
Osteoarthritis: pathogenic signaling pathways and therapeutic targets
Yao, Q., Wu, X., Tao, C., Gong, W., Chen, M., Qu, M., Zhong, Y., He, T., Chen, S., & Xiao, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01330-w · Cited by 1,194 · cited 1×
“Currently, OA management primarily focuses on symptom relief, joint function improvement, and quality of life enhancement, as no treatments are available to reverse cartilage degeneration [10].”
Stem cell therapy in a caprine model of osteoarthritis
Murphy, J. M., Fink, D. J., Hunziker, E. B., & Barry, F. P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11365 · Cited by 1,102 · cited 1×
“In sheep and goat models, some studies reported improvements, while others found no significant differences be-tween MSC-treated and control groups [89,90].”
Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential
Song, N., Scholtemeijer, M., & Shah, K. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.009 · Cited by 948 · cited 2×
“MSCs inhibit the activation and proliferation of immune cells, such as T cells and natural killer cells, reducing inflammation and preventing excessive tissue damage [40,41].”
Jo, C. H., Lee, Y. G., Shin, W. H., Kim, H., Chai, J. W., Jeong, E. C., Kim, J. E., Shim, H., Shin, J. S., Shin, I. S., et al. (2014) · STEM CELLS · doi:10.1002/stem.1634 · Cited by 911 · cited 3×
“Magnetic resonance imaging revealed decreased cartilage defects and increased cartilage volume in treated knees [168,169].”
InfluentialDing, D.-C., Shyu, W.-C., & Lin, S.-Z. (2011) · Cell Transplantation · doi:10.3727/096368910x · Cited by 894 · cited 3×
“Other potential sources include dental pulp, synovial membrane, and placental tissue, all of which contribute to the expanding range of options for MSC-based therapies [16].”
InfluentialSelf-citationRisk factors in the development of stem cell therapy
Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-29 · Cited by 753 · cited 3×
“Although most small-scale clinical trials using MSCs have not reported major health concerns, some serious adverse events have occurred, emphasizing the need for continued research on their long-Int term safety [214].”
Han, Y., Yang, J., Fang, J., Zhou, Y., Candi, E., Wang, J., Hua, D., Shao, C., & Shi, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00932-0 · Cited by 720 · cited 3×
“These cells modulate immune responses through secretion of various bioactive factors, including cytokines, growth factors, and extracellular vesicles (EVs), which help create a favorable microenvironment for tissue repair [38,39].”
Off-target effects in CRISPR/Cas9 gene editing
Guo, C., Ma, X., Gao, F., & Guo, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1143157 · Cited by 704 · cited 2×
“CRISPR/Cas9 gene editing has shown promise for treating diseases, but off-target effects remain a significant concern [154,155].”
Immune modulation by mesenchymal stem cells
Jiang, W., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12712 · Cited by 650 · cited 1×
“MSCs inhibit the activation and proliferation of immune cells, such as T cells and natural killer cells, reducing inflammation and preventing excessive tissue damage [40,41].”
Secretion of immunoregulatory cytokines by mesenchymal stem cells
Kyurkchiev, D. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.552 · Cited by 617 · cited 1×
“Through the release of cytokines and growth factors, MSCs suppress the activity of pro-inflammatory T helper (Th1) cells and enhance the generation of regulatory T cells (Tregs), promoting an anti-inflammatory state [75].”
Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy
Ding, D.-C., Chang, Y.-H., Shyu, W.-C., & Lin, S.-Z. (2015) · Cell Transplantation · doi:10.3727/096368915x686841 · Cited by 613 · cited 2×
“In addition to their differentiation potential, MSCs exhibit strong immunomodulatory and anti-inflammatory properties [19], which help reduce inflammation and support tissue repair in osteoarthritic joints [20].”
Self-citationvon Bahr, L., Batsis, I., Moll, G., Hägg, M., Szakos, A., Sundberg, B., Uzunel, M., Ringden, O., & Le Blanc, K. (2012) · Stem Cells · doi:10.1002/stem.1118 · Cited by 577 · cited 1×
“Other research indicates that MSCs have a limited lifespan [53].”
Vega, A., Martín-Ferrero, M. A., Del Canto, F., Alberca, M., García, V., Munar, A., Orozco, L., Soler, R., Fuertes, J. J., Huguet, M., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000678 · Cited by 571 · cited 3×
“For example, a randomized controlled trial demonstrated that allogeneic bone marrow MSCs improve pain, function, and cartilage quality in patients with knee OA compared with hyaluronic acid injections [58].”
InfluentialA brief history of nearly EV‐erything – The rise and rise of extracellular vesicles
Couch, Y., Buzàs, E. I., Di Vizio, D., Gho, Y. S., Harrison, P., Hill, A. F., Lötvall, J., Raposo, G., Stahl, P. D., Théry, C., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12144 · Cited by 566 · cited 1×
“EVs are small, membrane-enclosed structures released by cells into the extracellular space, ranging in size from 30 nm to 5 µ m [128].”
Lee, W.-S., Kim, H. J., Kim, K.-I., Kim, G. B., & Jin, W. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0122 · Cited by 497 · cited 2×
“Clinical trials have shown improvements in pain, function, and quality of life following MSC injections [168–170].”
Park, Y.-B., Ha, C.-W., Lee, C.-H., Yoon, Y. C., & Park, Y.-G. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0157 · Cited by 446 · cited 1×
“Long-term follow-up studies have reported durable cartilage regeneration and improved clinical outcomes without significant adverse events [96].”
Wu, M., Wu, S., Chen, W., & Li, Y.-P. (2024) · Cell Research · doi:10.1038/s41422-023-00918-9 · Cited by 445 · cited 1×
“Growth factors, such as TGF-β , fibroblast growth factor (FGF), and insulin-like growth factor (IGF), promote chondrocyte proliferation and enhance the production of key ECM components, such as collagen and proteoglycans, which are essential for cartilage repair [67,68].”
Ayhan, E. (2014) · World Journal of Orthopedics · doi:10.5312/wjo.v5.i3.351 · Cited by 441 · cited 1×
“In more severe cases, intra-articular injections, such as corticosteroids or hyaluronic acid, may provide temporary relief [13].”
Preconditioning influences mesenchymal stem cell properties in vitro and in vivo
Hu, C., & Li, L. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13492 · Cited by 438 · cited 1×
“Preconditioning MSCs with physical, chemical, and biological factors can help maintain their stemness and improve their activities both in vitro and in vivo [228].”
Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy
Phinney, D. G. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24166 · Cited by 434 · cited 1×
“MSCs exhibit significant heterogeneity in morphology, phenotype, and function, which poses challenges for their therapeutic applications [101,102].”
Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Büscher, D., Fibbe, W., Foussat, A., Kwa, M., et al. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.03.005 · Cited by 415 · cited 1×
“Regulatory bodies have addressed the potential tumorigenicity of MSCs through quality control measures and nonclinical and clinical assessments [216].”
Transforming growth factor‐β in stem cells and tissue homeostasis
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414 · cited 1×
“When combined with growth factors, like TGF-β or BMPs, the regenerative effects of MSCs are amplified, promoting cartilage repair and reducing joint degradation [181,182].”
The epidemiology of osteoarthritis in Asia
FRANSEN, M., BRIDGETT, L., MARCH, L., HOY, D., PENSERGA, E., & BROOKS, P. (2011) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2011.01608.x · Cited by 393 · cited 1×
“Cartilage degeneration is a common feature of both aging and osteoarthritis (OA), leading to impaired joint function [1].”
Chondrogenic Differentiation of Mesenchymal Stem Cells: Challenges and Unfulfilled Expectations
Somoza, R. A., Welter, J. F., Correa, D., & Caplan, A. I. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0771 · Cited by 359 · cited 1×
“Although MSCs can differentiate into chondrocyte-like cells, they often produce fibrocartilage and may undergo hypertrophy, leading to mineralization and vascularization [206].”
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications
Gowen, A., Shahjin, F., Chand, S., Odegaard, K. E., & Yelamanchili, S. V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00149 · Cited by 334 · cited 1×
“However, EV research is confronted with challenges in production methods, characterization, pharmacokinetics, and safety assessments, which need to be addressed before clinical application can proceed [118].”
Lamo-Espinosa, J. M., Mora, G., Blanco, J. F., Granero-Moltó, F., Nuñez-Córdoba, J. M., Sánchez-Echenique, C., Bondía, J. M., Aquerreta, J. D., Andreu, E. J., Ornilla, E., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0998-2 · Cited by 329 · cited 1×
“Similarly, autologous bone marrow MSCs exhibited long-term clinical benefits, with both low (10 × 10 6 ) and high (100 × 10 6 ) doses outperforming hyaluronic acid in pain reduction and functional improvement [159,160].”
Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
Caplan, H., Olson, S. D., Kumar, A., George, M., Prabhakara, K. S., Wenzel, P., Bedi, S., Toledano-Furman, N. E., Triolo, F., Kamhieh-Milz, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01645 · Cited by 306 · cited 2×
“Optimizing cell delivery methods, addressing hemocompatibility issues, and ensuring safety are crucial for successful clinical translation [100].”
Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives
Harrell, C. R., Markovic, B. S., Fellabaum, C., Arsenijevic, A., & Volarevic, V. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.099 · Cited by 301 · cited 2×
“Despite these risks, MSCs remain a promising therapeutic option for OA, offering regenerative potential and beneficial immunomodulatory effects [213].”
Frisbie, D. D., Kisiday, J. D., Kawcak, C. E., Werpy, N. M., & McIlwraith, C. W. (2009) · Journal of Orthopaedic Research · doi:10.1002/jor.20933 · Cited by 299 · cited 1×
“A study using horses found no significant treatment effects on gross pathological observations [91].”
Aghajanian, P., & Mohan, S. (2018) · Bone Research · doi:10.1038/s41413-018-0021-z · Cited by 284 · cited 2×
“This chondrocyte-to-osteoblast transdifferentiation occurs through three models: direct transdifferentiation, dedifferentiation to redifferentiation, and chondrocyte to osteogenic precursor [120].”
Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy
Sarugaser, R., Hanoun, L., Keating, A., Stanford, W. L., & Davies, J. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006498 · Cited by 260 · cited 1×
“This property is crucial for tissue regeneration, as it enables the expansion of MSCs in vitro before transplantation [28].”
Immunogenicity of Extracellular Vesicles
Xia, Y., Zhang, J., Liu, G., & Wolfram, J. (2024) · Advanced Materials · doi:10.1002/adma.202403199 · Cited by 256 · cited 1×
“Moreover, EVs exhibit low immunogenicity, making them suitable for repeated administration and potentially for allogeneic use [139,140].”
Saeedi, P., Halabian, R., & Imani Fooladi, A. A. (2019) · Stem Cell Investigation · doi:10.21037/sci.2019.08.11 · Cited by 251 · cited 1×
“While MSCs are generally considered safe, potential risks include tumorigenicity, unwanted immune responses, and transmission of adventitious agents [214,215].”
Effects of Mesenchymal Stem Cell‐Derived Paracrine Signals and Their Delivery Strategies
Chang, C., Yan, J., Yao, Z., Zhang, C., Li, X., & Mao, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001689 · Cited by 248 · cited 1×
“Paracrine signaling plays a pivotal role in the therapeutic effects of MSCs, particularly in cartilage regeneration [65].”
Jo, C. H., Chai, J. W., Jeong, E. C., Oh, S., Shin, J. S., Shim, H., & Yoon, K. S. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517716641 · Cited by 240 · cited 5×
“Clinical trials have shown improvements in pain, function, and quality of life following MSC injections [168–170].”
InfluentialMesenchymal stem cells for cartilage regeneration
Le, H., Xu, W., Zhuang, X., Chang, F., Wang, Y., & Ding, J. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420943839 · Cited by 236 · cited 1×
“By directly contributing to cartilage tissue regeneration, MSC differentiation into chondrocytes represents a promising avenue for long-term joint repair and functional recovery [51].”
Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells: Tips and Tricks
Solchaga, L. A., Penick, K. J., & Welter, J. F. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60761-999-4_20 · Cited by 226 · cited 1×
“Bone marrow-derived MSCs (BM-MSCs) are the most extensively studied and show strong potential for differentiating into chondrocytes, making them a common choice for cartilage regeneration [23,24].”
Recent advances in intra-articular drug delivery systems for osteoarthritis therapy
Maudens, P., Jordan, O., & Allémann, E. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.023 · Cited by 226 · cited 1×
“Additionally, combining MSCs with drugs, such as anti-inflammatory agents or disease-modifying osteoarthritis drugs like kartogenin, can help control the inflammatory environment within the joint, further improving patient outcomes [183,184].”
Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications
Huang, Y., Wu, Q., & Tam, P. K. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710023 · Cited by 223 · cited 1×
“MSCs possess potent immunomodulatory and anti-inflammatory effects, making them a valuable therapeutic option for inflammatory conditions like OA [74].”
Sato, M., Uchida, K., Nakajima, H., Miyazaki, T., Guerrero, A. R., Watanabe, S., Roberts, S., & Baba, H. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3735 · Cited by 215 · cited 1×
“Interestingly, a study on Guinea pigs with spontaneously developing OA reported beneficial effects of MSC treatment [88].”
Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy
Fan, M., Pi, J.-K., Zou, C., Jiang, Y., Li, Q., Zhang, X., Xing, F., Nie, R., Chen, H., & Xie, H. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.04.007 · Cited by 208 · cited 1×
“Additionally, exploring the use of MSC-derived products, such as EVs or engineered scaffolds, may offer alternative or complementary strategies for cartilage repair [164,165].”
Cartilage repair by mesenchymal stem cells: Clinical trial update and perspectives
Lee, W. Y.-W., & Wang, B. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.03.005 · Cited by 207
Extracellular Vesicles: New Classification and Tumor Immunosuppression
Sheta, M., Taha, E. A., Lu, Y., & Eguchi, T. (2023) · Biology · doi:10.3390/biology12010110 · Cited by 206 · cited 3×
“EVs are involved in various physiological and pathological processes, including tumor immunosuppression and metastasis [130].”
InfluentialMatsumoto, T., Cooper, G. M., Gharaibeh, B., Meszaros, L. B., Li, G., Usas, A., Fu, F. H., & Huard, J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24443 · Cited by 203 · cited 1×
“Preclinical studies have shown that MSCs significantly enhance cartilage repair in various species, including mice [17], rats [79], rabbits [18], and larger animals, such as pigs [80], sheep [81], and horses [82].”
Pharmacological Methods of Pain Management: Narrative Review of Medication Used
Alorfi, N. M. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s419239 · Cited by 200 · cited 1×
“Pharmacological options include acetaminophen and nonsteroidal anti-inflammatory drugs to manage pain and inflammation [12].”
Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine
González-González, A., García-Sánchez, D., Dotta, M., Rodríguez-Rey, J. C., & Pérez-Campo, F. M. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i12.1529 · Cited by 198 · cited 1×
“Rather than relying solely on direct differentiation into chondrocytes, MSCs exert much of their regenerative potential by secreting a variety of bioactive molecules, including growth factors, cytokines, and EVs [66].”
Cartilage Homeostasis and Osteoarthritis
Fujii, Y., Liu, L., Yagasaki, L., Inotsume, M., Chiba, T., & Asahara, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116316 · Cited by 195 · cited 2×
“Understanding these processes is essential for developing treatments for skeletal diseases and OA, which involves disruptions in chondrocyte homeostasis [122].”
Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
Lee, B.-C., Kang, I., & Yu, K.-R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040711 · Cited by 189 · cited 1×
“Various strategies, including the use of scaffolds, exosomes, and hydrogels, have been explored to improve MSC retention, survival, and functionality at the injury site [171,172].”
Osteoarthritis and stem cell therapy in humans: a systematic review
Jevotovsky, D. S., Alfonso, A. R., Einhorn, T. A., & Chiu, E. S. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.02.906 · Cited by 187 · cited 1×
“However, a systematic review of 61 studies, including 14 high-quality trials, indicated inconsistency in MSC preparation methods and limited long-term follow-up data [212].”
Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
Li, C., Zhao, H., Cheng, L., & Wang, B. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00698-y · Cited by 186 · cited 1×
“This personalized approach enables for optimization of MSC source (whether autologous or allogeneic), dosage, and potential combination with other therapies, such as growth factors or drugs, ensuring that the therapy is best suited to the individual’s condition [197,198].”
Lamo-Espinosa, J. M., Mora, G., Blanco, J. F., Granero-Moltó, F., Núñez-Córdoba, J. M., López-Elío, S., Andreu, E., Sánchez-Guijo, F., Aquerreta, J. D., Bondía, J. M., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1591-7 · Cited by 182 · cited 1×
“Similarly, autologous bone marrow MSCs exhibited long-term clinical benefits, with both low (10 × 10 6 ) and high (100 × 10 6 ) doses outperforming hyaluronic acid in pain reduction and functional improvement [159,160].”
Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair
Fellows, C. R., Matta, C., Zakany, R., Khan, I. M., & Mobasheri, A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00213 · Cited by 180 · cited 2×
“Despite these obstacles, MSC-based therapies remain a promising area of research, offering potential solutions to the limitations of current cartilage repair strategies [208,209].”
Signaling Pathways in Cartilage Repair
Mariani, E., Pulsatelli, L., & Facchini, A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058667 · Cited by 179 · cited 1×
“Growth factors, such as TGF-β , fibroblast growth factor (FGF), and insulin-like growth factor (IGF), promote chondrocyte proliferation and enhance the production of key ECM components, such as collagen and proteoglycans, which are essential for cartilage repair [67,68].”
Applications of Biocompatible Scaffold Materials in Stem Cell-Based Cartilage Tissue Engineering
Zhao, X., Hu, D. A., Wu, D., He, F., Wang, H., Huang, L., Shi, D., Liu, Q., Ni, N., Pakvasa, M., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.603444 · Cited by 172 · cited 1×
“Scaffolds, typically made from biocompatible materials, provide a structural framework that mimics the cartilage matrix, supporting MSC differentiation into chondrocytes and promoting ECM production [123,173].”
Strategies to minimize hypertrophy in cartilage engineering and regeneration
Chen, S., Fu, P., Cong, R., Wu, H., & Pei, M. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.003 · Cited by 167 · cited 1×
“Successful cartilage regeneration requires the optimization of MSC sources, growth factors, and scaffolds to promote stable chondrogenesis while preventing hypertrophy [207].”
Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics
Yin, B., Ni, J., Witherel, C. E., Yang, M., Burdick, J. A., Wen, C., & Wong, S. H. D. (2022) · Theranostics · doi:10.7150/thno.62708 · Cited by 164 · cited 1×
“Moreover, EVs exhibit low immunogenicity, making them suitable for repeated administration and potentially for allogeneic use [139,140].”
Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis
Xiang, X.-N., Zhu, S.-Y., He, H.-C., Yu, X., Xu, Y., & He, C.-Q. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02689-9 · Cited by 164 · cited 1×
“When combined with growth factors, like TGF-β or BMPs, the regenerative effects of MSCs are amplified, promoting cartilage repair and reducing joint degradation [181,182].”
Costela-Ruiz, V. J., Melguizo-Rodríguez, L., Bellotti, C., Illescas-Montes, R., Stanco, D., Arciola, C. R., & Lucarelli, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116356 · Cited by 162 · cited 1×
“%) abilities, making them preferable compared to DeP-MSCs [32]. for orthopedic applications [33].”
Exosomes and stem cells in degenerative disease diagnosis and therapy
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C. (2018) · Cell Transplantation · doi:10.1177/0963689717723636 · Cited by 159 · cited 1×
“These vesicles, including exosomes, are naturally secreted by MSCs and carry bioactive molecules, such as proteins, lipids, and RNAs, that facilitate intercellular communication and tissue repair [134].”
Self-citationEMADEDIN, M., LABIBZADEH, N., LIASTANI, M. G., KARIMI, A., JAROUGHI, N., BOLURIEH, T., HOSSEINI, S.-E., BAHARVAND, H., & AGHDAMI, N. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.08.005 · Cited by 155 · cited 1×
“Cell doses ranging from 24 to 100 million have been investigated, with moderate doses (40 million) appearing optimal for efficacy and safety [61,62].”
Narcisi, R., Cleary, M. A., Brama, P. A. J., Hoogduijn, M. J., Tüysüz, N., ten Berge, D., & van Osch, G. J. V. M. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.01.017 · Cited by 148 · cited 3×
“During expansion, MSCs tend to lose proliferation and differentiation capacity, particularly in osteogenesis and adipogenesis, although their chondrogenic potential is better preserved [203].”
InfluentialDiekman, B. O., Wu, C., Louer, C. R., Furman, B. D., Huebner, J. L., Kraus, V. B., Olson, S. A., & Guilak, F. (2012) · Cell Transplantation · doi:10.3727/096368912x653264 · Cited by 148 · cited 1×
“Mice models showed promising results in fracture-induced and collagenase-induced OA [87].”
Advancements in hydrogel design for articular cartilage regeneration: A comprehensive review
Hashemi-Afzal, F., Fallahi, H., Bagheri, F., Collins, M. N., Eslaminejad, M. B., & Seitz, H. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.005 · Cited by 144 · cited 1×
“By contrast, hydrogels offer a flexible and dynamic environment that encapsulates MSCs, protecting them from degradation while delivering them precisely to damaged cartilage [174].”
Fernández-Santos, M. E., Garcia-Arranz, M., Andreu, E. J., García-Hernández, A. M., López-Parra, M., Villarón, E., Sepúlveda, P., Fernández-Avilés, F., García-Olmo, D., Prosper, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918565 · Cited by 139 · cited 1×
“This personalized approach enables for optimization of MSC source (whether autologous or allogeneic), dosage, and potential combination with other therapies, such as growth factors or drugs, ensuring that the therapy is best suited to the individual’s condition [197,198].”
Role of mesenchymal stem cells in osteoarthritis treatment
Kong, L., Zheng, L., Qin, L., & Ho, K. K. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.03.006 · Cited by 136 · cited 1×
“MSCs have shown promise in OA treatment due to their differentiation potential and immunomodulatory effects, though further research is needed to evaluate safety and effectiveness [179].”
Salazar-Noratto, G. E., Luo, G., Denoeud, C., Padrona, M., Moya, A., Bensidhoum, M., Bizios, R., Potier, E., Logeart‐Avramoglou, D., & Petite, H. (2019) · Stem Cells · doi:10.1002/stem.3079 · Cited by 135 · cited 1×
“The hostile environment at transplantation sites, characterized by low oxygen and nutrients, negatively impacts MSC metabolism and survival [225].”
Moya, A., Paquet, J., Deschepper, M., Larochette, N., Oudina, K., Denoeud, C., Bensidhoum, M., Logeart‐Avramoglou, D., & Petite, H. (2017) · Stem Cells · doi:10.1002/stem.2763 · Cited by 134 · cited 1×
“Under near-anoxic conditions, MSCs rely almost exclusively on glucose for ATP production through anaerobic glycolysis and possess limited internal glucose reserves [72].”
Equine Models of Articular Cartilage Repair
McIlwraith, C. W., Fortier, L. A., Frisbie, D. D., & Nixon, A. J. (2011) · Cartilage · doi:10.1177/1947603511406531 · Cited by 128 · cited 1×
“Preclinical studies have shown that MSCs significantly enhance cartilage repair in various species, including mice [17], rats [79], rabbits [18], and larger animals, such as pigs [80], sheep [81], and horses [82].”
The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review
Česnik, A. B., & Švajger, U. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1400347 · Cited by 128 · cited 3×
“MSCs exhibit significant heterogeneity, which poses challenges for their clinical applications [101,217].”
Biogenesis of Extracellular Vesicles
Kang, T., Atukorala, I., & Mathivanan, S. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_2 · Cited by 121 · cited 1×
“They play crucial roles in cell-to-cell communication by transferring functional biomolecules between cells [129].”
Liang, J., Liu, P., Yang, X., Liu, L., Zhang, Y., Wang, Q., & Zhao, H. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.08.006 · Cited by 121 · cited 1×
“Furthermore, the joint microenvironment, along with scaffold materials or biomimetic surfaces, enhances the successful differentiation of MSCs into chondrocytes [50].”
Mesenchymal stromal cells for cartilage repair in osteoarthritis
Mamidi, M. K., Das, A. K., Zakaria, Z., & Bhonde, R. R. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.03.003 · Cited by 120 · cited 1×
“While MSCs demonstrate cartilage repair potential and immunomodulatory properties in preclinical studies, understanding cell behavior post-transplantation and enhancing potency within disease microenvironments remain important goals [117].”
Kim, Y. S., Kwon, O. R., Choi, Y. J., Suh, D., Heo, D. B., & Koh, Y. G. (2015) · The American Journal of Sports Medicine · doi:10.1177/0363546515599632 · Cited by 119 · cited 1×
“Injecting MSCs in gel form into the articular cavity has demonstrated improved patient outcomes [54], though implanting MSCs directly into cartilage defects under arthroscopy has shown even greater benefits [55].”
Ren, H., Sang, Y., Zhang, F., Liu, Z., Qi, N., & Chen, Y. (2016) · Stem Cells International · doi:10.1155/2016/3516574 · Cited by 117 · cited 1×
“…potential and lower apoptosis rates Dental pulp (DP)-MSCs demonstrate superior osteogenic differentiation potential and lower apoptosis rates compared to UC-MSCs, but UC-MSCs exhibit higher proliferation capacity [35]. compared to UC-MSCs, but UC-MSCs exhibit higher proliferation capacity [35].”
Chiang, E., Ma, H., Wang, J., Liu, C., Chen, T.-H., & Hung, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149835 · Cited by 115 · cited 1×
“In rabbits, most studies found improvements in cartilage repair and reduced osteoarthritis progression based on histological and radiological assessments [86].”
Cell-based approaches to joint surface repair: a research perspective
Roelofs, A. J., Rocke, J., & Bari, C. D. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.04.008 · Cited by 112 · cited 2×
“Key challenges include ensuring the quality and durability of the repair tissue, achieving integration with surrounding host tissue, and preventing endochondral ossification [209].”
Enhanced In Vitro Chondrogenesis of Primary Mesenchymal Stem Cells by Combined Gene Transfer
Steinert, A. F., Palmer, G. D., Pilapil, C., Nöth, U. A., Evans, C. H., & Ghivizzani, S. C. (2008) · Tissue Engineering Part A · doi:10.1089/ten.tea.2007.0252 · Cited by 110 · cited 1×
“Additionally, bottom-up strategies, such as gene delivery, gene editing, and subpopulation isolation, have been investigated to enhance MSC behavior for cartilage tissue engineering [152,153].”
Varela-Eirín, M., Varela-Vázquez, A., Guitián‐Caamaño, A., Paíno, C. L., Mato‐Abad, V., Largo, R., Aasen, T., Tabernero, A., Fonseca, E., Kandouz, M., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1225-2 · Cited by 110 · cited 2×
“Aged chondrocytes also exhibit signs of senescence, producing inflammatory molecules that further inhibit cartilage regeneration [7].”
The role of secreted factors in stem cells-mediated immune regulation
Lin, L., & Du, L. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2017.07.010 · Cited by 107 · cited 1×
“Additionally, MSCs secrete factors, such as PGE-2, CCL-2, and micro-RNAs, that promote the recruitment of regulatory immune cells, regulating the polarization, migration, and function of macrophages and enhancing their ability to control inflammation [44].”
Cellular therapy and tissue engineering for cartilage repair
Zelinka, A. A., Roelofs, A. J., Kandel, R. A., & Bari, C. D. (2022) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2022.07.012 · Cited by 106 · cited 1×
“Establishing standardized protocols for MSC preparation and administration, along with long-term follow-up, will be essential for translating these therapies into routine clinical practice [166].”
Carneiro, D. D. C., de Araújo, L. T., Santos, G. C., Damasceno, P. K. F., Vieira, J. L., dos Santos, R. R., Barbosa, J. D. V., & Soares, M. B. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129939 · Cited by 106 · cited 4×
“Intra-articular MSC injections have shown encouraging results in cartilage regeneration, although achieving complete repair of articular cartilage defects remains challenging [94].”
InfluentialKim, Y. S., Choi, Y. J., & Koh, Y. G. (2015) · The American Journal of Sports Medicine · doi:10.1177/0363546515588317 · Cited by 102 · cited 1×
“Injecting MSCs in gel form into the articular cavity has demonstrated improved patient outcomes [54], though implanting MSCs directly into cartilage defects under arthroscopy has shown even greater benefits [55].”
Doyle, E. C., Wragg, N. M., & Wilson, S. L. (2020) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-020-05859-z · Cited by 102 · cited 3×
“Cell doses ranging from 24 to 100 million have been investigated, with moderate doses (40 million) appearing optimal for efficacy and safety [61,62].”
Wang, A.-T., Feng, Y., Jia, H.-H., Zhao, M., & Yu, H. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i4.222 · Cited by 100 · cited 1×
“Personalized regenerative medicine using MSCs for OA holds significant potential because it provides treatments tailored to individual’s needs [191].”
MSC Therapy for Osteoarthritis: An Unfinished Story
Barry, F. (2019) · Journal of Orthopaedic Research · doi:10.1002/jor.24343 · Cited by 100 · cited 1×
“While both adipose-derived and bone marrow-derived MSCs have been studied, their effectiveness remains uncertain [211].”
Zha, K., Sun, Z., Yu, Y., Chen, M., Gao, C., Fu, L., Li, H., Sui, X., Guo, Q., & Liu, S. (2021) · Stem Cells International · doi:10.1155/2021/8830834 · Cited by 95 · cited 3×
“Continued research in MSC engineering and chondrogenic differentiation is crucial for advancing cartilage tissue engineering and developing effective treatments for joint diseases [145,146].”
Exercise for Osteoarthritis: A Literature Review of Pathology and Mechanism
Kong, H., Wang, X., & Zhang, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.854026 · Cited by 95 · cited 1×
“Pain management is essential to OA treatment and often begins with non-pharmacological interventions, such as weight loss, physical therapy, and exercise, which help reduce joint stress and improve mobility [11].”
A Review on the Management of Hip and Knee Osteoarthritis
Wood, A. M., Brock, T. M., Heil, K., Holmes, R., & Weusten, A. (2013) · International Journal of Chronic Diseases · doi:10.1155/2013/845015 · Cited by 94 · cited 1×
“Joint replacement surgery effectively alleviates pain and restores function but is typically reserved for end-stage OA due to its invasive nature and the potential need for revision surgeries over time [15].”
Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context
Esmaeili, A., Alini, M., Baghaban Eslaminejad, M., & Hosseini, S. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02806-2 · Cited by 94 · cited 1×
“By customizing the content and surface properties of EVs, researchers can enhance their stability, targeting capabilities, and therapeutic efficacy [137].”
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Potential
Zhao, A. G., Shah, K., Cromer, B., & Sumer, H. (2020) · Stem Cells International · doi:10.1155/2020/8825771 · Cited by 93 · cited 2×
“Mesenchymal stromal cell-derived EVs (MSC-EVs) present a promising alternative to cell-based therapies for tissue regeneration and disease treatment [141].”
Szabó, E., Fajka-Boja, R., Kriston-Pál, É., Hornung, Á., Makra, I., Kudlik, G., Uher, F., Katona, R. L., Monostori, É., & Czibula, Á. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0581 · Cited by 92
State of the Art: The Immunomodulatory Role of MSCs for Osteoarthritis
Kwon, D. G., Kim, M. K., Jeon, Y. S., Nam, Y. C., Park, J., & Ryu, D. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031618 · Cited by 90 · cited 1×
“As a result, MSCs are considered a promising candidate for regenerative therapies targeting joint disorders [45].”
Regmi, S., Raut, P. K., Pathak, S., Shrestha, P. S., Park, P., & Jeong, J. (2020) · Autophagy · doi:10.1080/15548627.2020.1850608 · Cited by 87 · cited 2×
“Three-dimensional (3D) culturing of MSCs induces autophagy and suppresses ROS production, leading to improved cell viability [222].”
Gene Modification of Mesenchymal Stem Cells and Articular Chondrocytes to Enhance Chondrogenesis
Gurusinghe, S., & Strappe, P. (2014) · BioMed Research International · doi:10.1155/2014/369528 · Cited by 86
Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering
Xu, X., Xu, L., Xia, J., Wen, C., Liang, Y., & Zhang, Y. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.07.024 · Cited by 86 · cited 2×
“Through these paracrine actions, MSCs enhance tissue regeneration, protect existing cartilage from further damage, and create a favorable environment for joint repair, making paracrine signaling a critical mechanism in MSC-based therapies for OA and cartilage degeneration [69].”
Chen, X., Tang, H., Lin, J., & Zeng, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288561 · Cited by 85 · cited 2×
“Socio-demographic factors play a role, with a positive association between age-standardized incidence rates and the Socio-demographic Index [3].”
InfluentialMesenchymal cells condensation-inducible mesh scaffolds for cartilage tissue engineering
Kim, I. G., Ko, J., Lee, H. R., Hee, S., & Park, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.048 · Cited by 83 · cited 1×
“…differentiation of bone marrow-derived MSCs [126] Additionally, poly(l-lactide-co-glycolide)/poly(l-lactide) microfiber scaffolds coated with human fibroblast-derived matrix and immobilized with TGF-β 1 have promoted MSC condensation and improved chondro-genesis both in vitro and in vivo [127].”
Role of MSC‐derived small extracellular vesicles in tissue repair and regeneration
Koga, B. A. A., Fernandes, L. A., Fratini, P., Sogayar, M. C., & Carreira, A. C. O. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1047094 · Cited by 83 · cited 1×
“These cells modulate immune responses through secretion of various bioactive factors, including cytokines, growth factors, and extracellular vesicles (EVs), which help create a favorable microenvironment for tissue repair [38,39].”
Human extracellular matrix (ECM)-like collagen and its bioactivity
Zhou, H., Li, W., Pan, L., Zhu, T., Zhou, T., Xiao, E., & Wei, Q. (2024) · Regenerative Biomaterials · doi:10.1093/rb/rbae008 · Cited by 83 · cited 1×
“This reduction results in decreased production of essential extracellular matrix (ECM) components, such as collagen and proteoglycans, leading to a loss of cartilage structural integrity, thickness, and elasticity [9].”
Deschepper, M., Manassero, M., Oudina, K., Paquet, J., Monfoulet, L., Bensidhoum, M., Logeart‐Avramoglou, D., & Petite, H. (2012) · Stem Cells · doi:10.1002/stem.1299 · Cited by 82 · cited 2×
“Studies have shown that glucose deprivation, more than oxygen shortage, severely compromises MSC viability and functional maturation [70,71].”
The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming
Luque-Campos, N., Bustamante-Barrientos, F. A., Pradenas, C., García, C., Araya, M. J., Bohaud, C., Contreras-López, R., Elizondo-Vega, R., Djouad, F., Luz-Crawford, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624746 · Cited by 82 · cited 1×
“Additionally, MSCs induce a shift in macrophages from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, further reducing joint inflammation [76].”
Hazrati, A., Malekpour, K., Soudi, S., & Hashemi, S. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113943 · Cited by 82 · cited 1×
“Gene editing techniques, particularly CRISPR/Cas9, have shown promise in modifying MSCs to improve their chondrogenic potential [146–148].”
Lopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82 · cited 3×
“These unintended alterations can include small indels, large deletions, and structural variations, posing risks to patients [155].”
Adipose-Derived Mesenchymal Stromal Cells in Basic Research and Clinical Applications
Czerwiec, K., Zawrzykraj, M., Deptuła, M., Skoniecka, A., Tymińska, A., Zieliński, J., Kosiński, A., & Pikuła, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043888 · Cited by 80 · cited 1×
“Adipose tissue (AT)-derived MSCs offer a more abundant and accessible source, with high cell yields and regenerative potential comparable with bone marrow-derived MSCs [26].”
Anti-Inflammatory Strategies in Cartilage Repair
Zhang, Y., Pizzute, T., & Pei, M. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2014.0014 · Cited by 78 · cited 1×
“These anti-inflammatory actions help mitigate the chronic inflammation typically associated with OA, thereby protecting cartilage from further degradation and creating a more conducive environment for tissue repair [77,78].”
Ding, D.-C., Chou, H.-L., Chang, Y.-H., Hung, W.-T., Liu, H.-W., & Chu, T.-Y. (2016) · Cell Transplantation · doi:10.3727/096368915x688182 · Cited by 72 · cited 3×
“MSCs exhibit strong immunosuppressive properties mediated by HLA-G expression, which can inhibit the proliferation of peripheral blood mononuclear cells and the expression of inflammatory cytokines [19].”
Self-citationEngineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis
Cheng, J., Sun, Y., Ma, Y., Ao, Y., Hu, X., & Meng, Q. (2022) · Membranes · doi:10.3390/membranes12080739 · Cited by 72 · cited 1×
“Exosomes, small vesicles secreted by MSCs, are emerging as a promising cell-free alternative, capable of delivering therapeutic molecules like proteins and RNAs to promote cartilage regeneration [176].”
Advancing Mesenchymal Stem Cell Therapy with CRISPR/Cas9 for Clinical Trial Studies
Golchin, A., Shams, F., & Karami, F. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_459 · Cited by 70 · cited 1×
“While CRISPR/Cas9 offers precise gene targeting, further research is needed to optimize MSC-based therapies for clinical applications [151].”
Renesme, L., Pierro, M., Cobey, K. D., Mital, R., Nangle, K., Shorr, R., Lalu, M. M., & Thébaud, B. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab009 · Cited by 69 · cited 2×
“The International Society for Cell and Gene Therapy (ISCT) minimal criteria for defining MSCs consist of three main components: plastic adherence, specific surface antigen expression, and multipotent differentiation potential [29].”
Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation
Rady, D., Abbass, M. M. S., El-Rashidy, A. A., El Moshy, S., Radwan, I. A., Dörfer, C. E., & Fawzy El-Sayed, K. M. (2020) · Stem Cells International · doi:10.1155/2020/8837654 · Cited by 68 · cited 2×
“Despite these advancements, challenges persist in clinical translation, such as population heterogeneity, variability in isolation and expansion protocols, and safety concerns regarding teratogenic potential [99].”
Zellner, J., Pattappa, G., Koch, M., Lang, S., Weber, J., Pfeifer, C., Mueller, M. B., Kujat, R., Nerlich, M. L., & Angele, P. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0678-z · Cited by 67 · cited 1×
“In an animal study, bone marrow-derived MSCs cultured and implanted with a collagen-hyaluronic acid scaffold significantly enhanced type II collagen [56].”
Thorp, H., Kim, K.-S., Kondō, M., Maak, T. G., Grainger, D. W., & Okano, T. (2021) · Cells · doi:10.3390/cells10030643 · Cited by 66 · cited 2×
“Three-dimensional cell sheet technology has emerged as a promising approach for fabricating hyaline-like cartilage constructs [199].”
Wruck, W., Graffmann, N., Spitzhorn, L., & Adjaye, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.717772 · Cited by 64 · cited 3×
“Additionally, the generation of induced pluripotent stem cell-derived MSCs (iMSCs) has emerged as a promising approach to reduce age-and tissue-related heterogeneity through epigenetic rejuvenation [219].”
Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations
Chen, S., Liang, B., & Xu, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05294-5 · Cited by 63 · cited 5×
“To address this issue, researchers have explored marker-based isolation strategies to purify MSC subpopulations [101,218].”
InfluentialSheep as a model for evaluating mesenchymal stem/stromal cell (MSC)-based chondral defect repair
Music, E., Futrega, K., & Doran, M. R. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.03.006 · Cited by 61 · cited 1×
“Preclinical studies have shown that MSCs significantly enhance cartilage repair in various species, including mice [17], rats [79], rabbits [18], and larger animals, such as pigs [80], sheep [81], and horses [82].”
Tang, Y., Pan, Z., Zou, Y., He, Y., Yang, P., Tang, Q., & Yin, F. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13138 · Cited by 60 · cited 1×
“In various OA animal models, rats were commonly used, with studies reporting improved cartilage preservation and reduced damage after MSC injections [84,85].”
Xing, D., Kwong, J. S. W., Yang, Z., Hou, Y., Zhang, W., Ma, B., & Lin, J. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.01.010 · Cited by 60 · cited 3×
“Additionally, the evidence quality for all outcomes was either low or very low, highlighting the need for further high-quality research before drawing definitive conclusions about the efficacy of MSC treatments across species [84].”
Massaro, F., Corrillon, F., Stamatopoulos, B., Dubois, N., Ruer, A., Meuleman, N., Bron, D., & Lagneaux, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267550 · Cited by 60 · cited 1×
“However, their collection is invasive, and both their quantity and differentiation capability tend to decrease with age [25].”
Strategies for improved targeting of therapeutic cells: Implications for tissue repair
Ansboro, S., Greiser, U., Barry, F., & Murphy, M. J. (2012) · European Cells and Materials · doi:10.22203/ecm.v023a24 · Cited by 59 · cited 2×
“To address this, researchers have explored various strategies, including cell surface modification and the use of nanoparticles for improved targeting and gene delivery [57].”
Yin, L., Wu, Y., Yang, Z., Tee, C. A., Denslin, V., Lai, Z., Lim, C. T., Lee, E. H., & Han, J. (2018) · Lab on a Chip · doi:10.1039/c7lc01005b · Cited by 58 · cited 1×
“For instance, microfluidic selection of medium-sized MSCs (17–21 µ m) during expansion enhances proliferation and chondrogenic capacity [205].”
Guan, Y., Xie, Y., Li, D., Zhu, Y., Zhang, X., Feng, Y., Chen, Y.-P., Xu, L., Liao, P., & Wang, G. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10286 · Cited by 58 · cited 1×
“%) compared to DeP-MSCs [32].”
Engineered Extracellular Vesicles: A potential treatment for regeneration
Cheng, W., Xu, C., Su, Y., Shen, Y., Yang, Q., Zhao, Y., Zhao, Y., & Liu, Y. (2023) · iScience · doi:10.1016/j.isci.2023.108282 · Cited by 57 · cited 1×
“Engineered EVs have emerged as a novel approach for delivering MSC-derived factors to enhance cartilage regeneration [133].”
Matas, J., Garcia, C. M., Poblete, D., Vernal, R., Ortloff, A., Luque‐Campos, N., Hidalgo, Y., Cuenca, J., Infante, C., Cádiz, M. I., et al. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad088 · Cited by 57 · cited 1×
“A dose-escalation study using umbilical cord-derived MSCs found that all tested doses (2 × 10 6 , 20 × 10 6 , and 80 × 10 6 ) were safe and effective, with medium and low doses showing superior outcomes [161].”
Zhang, S., Xu, H., He, B., Fan, M., Xiao, M.-M., Zhang, J., Chen, D., Tong, P., & Mao, Q. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02788-1 · Cited by 56 · cited 1×
“Clinical trials have demonstrated the safety and potential efficacy of MSC-based therapies, with significant pain reduction reported in treated patients compared with controls [93].”
Factors that influence outcome in experimental osteoarthritis
van der Kraan, P. M. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.09.005 · Cited by 55 · cited 1×
“Overall, while most studies across species reported some degree of improvement after MSC treatment, the outcomes varied considerably [92].”
Ding, D., Wu, K., Chang, Y., & Liu, H.-W. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_87_18 · Cited by 54 · cited 3×
“Preclinical studies have shown that MSCs significantly enhance cartilage repair in various species, including mice [17], rats [79], rabbits [18], and larger animals, such as pigs [80], sheep [81], and horses [82].”
Self-citationSolanki, K., Shanmugasundaram, S., Shetty, N. D., & Kim, S.-J. (2021) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2021.101602 · Cited by 54 · cited 2×
“Key outcomes, such as sustained cartilage regeneration, functional improvements, and joint preservation, remain relatively understudied [163].”
Borakati, A., Mafi, R., Mafi, P., & Khan, W. S. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x12666170915120620 · Cited by 53 · cited 1×
“However, the heterogeneity of current clinical trials highlights the need for more robust and consistent studies to generate reliable evidence supporting MSC therapies for OA [94,97].”
Extracellular Vesicles in Regenerative Medicine: Potentials and Challenges
Lee, J. Y., & Kim, H.-S. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00365-w · Cited by 53 · cited 1×
“Despite these hurdles, the versatility and potential of EVs in regenerative medicine make them an exciting area of research for future therapeutic applications [132].”
González-Fernández, P., Rodríguez‐Nogales, C., Jordan, O., & Allémann, É. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.01.003 · Cited by 52 · cited 1×
“Additionally, combining MSCs with drugs, such as anti-inflammatory agents or disease-modifying osteoarthritis drugs like kartogenin, can help control the inflammatory environment within the joint, further improving patient outcomes [183,184].”
Farrell, M. J., Shin, J. I., Smith, L. J., & Mauck, R. L. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.09.012 · Cited by 49 · cited 1×
“Studies have shown that glucose deprivation, more than oxygen shortage, severely compromises MSC viability and functional maturation [70,71].”
Honarpardaz, A., Irani, S., Pezeshki‐Modaress, M., Zandi, M., & Sadeghi, A. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36501 · Cited by 49 · cited 1×
“…nanofiber scaffolds, particularly those containing 15% glycosaminoglycan, have enhanced chondrogenic differentiation of bone marrow-derived MSCs [126] Additionally, poly(l-lactide-co-glycolide)/poly(l-lactide) microfiber scaffolds coated with human fibroblast-derived matrix and immobilized with…”
Kim, Y. S., & Mikos, A. G. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.055 · Cited by 49 · cited 1×
“Additionally, bottom-up strategies, such as gene delivery, gene editing, and subpopulation isolation, have been investigated to enhance MSC behavior for cartilage tissue engineering [152,153].”
Rojewski, M., Lotfi, R., Gjerde, C., Mustafa, K., Veronesi, E., Ahmed, A. B., Wiesneth, M., Körper, S., Sensebé, L., Layrolle, P., et al. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.03.001 · Cited by 48 · cited 2×
“Rojewski et al. successfully translated a standardized protocol for bone marrow-derived MSCs from validation to clinical manufacturing, show-Int ing stable performance characteristics despite variations in starting material [106].”
Zhang, X., Liang, Y., Luo, D., Li, P., Chen, Y., Fu, X., Yue, Y., Hou, R., Liu, J., & Wang, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117386 · Cited by 48 · cited 1×
“Various strategies, including the use of scaffolds, exosomes, and hydrogels, have been explored to improve MSC retention, survival, and functionality at the injury site [171,172].”
Modification of mesenchymal stem cells for cartilage-targeted therapy
Huang, J., Liu, Q., Xia, J., Chen, X., Xiong, J., Yang, L., & Liang, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03726-8 · Cited by 47 · cited 4×
“The homing effect of MSCs to injured joints is a crucial factor in their therapeutic efficacy [21].”
InfluentialThe global burden of osteoarthritis: past and future perspectives
Wong, A. Y. L., Samartzis, D., & Maher, C. G. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00207-2 · Cited by 45 · cited 1×
“The burden of OA is expected to continue rising due to population growth, aging, and increasing obesity rates [5].”
The increase in total knee replacement surgery in Taiwan
Lin, F., Chen, H., Lin, C. S., Chiu, Y., Lee, H., Chang, H., Huang, G., Chang, H.-L., Yeh, S.-J., Su, W., et al. (2018) · Medicine · doi:10.1097/md.0000000000011749 · Cited by 44 · cited 1×
“In Taiwan, the overall crude incidence of total knee replacement rose from 26.4 to 74.55 per 100,000 persons between 1996 and 2010 [6].”
InfluentialReinders, M. E. J., Groeneweg, K. E., Hendriks, S. H., Bank, J. R., Dreyer, G. J., de Vries, A. P. J., van Pel, M., Roelofs, H., Huurman, V. A. L., Meij, P., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16528 · Cited by 44 · cited 2×
“Studies have demonstrated the safety of MSC infusion after liver transplantation [113] and kidney transplantation [114].”
Kim, K., Lee, W.-S., Kim, J., Bae, J.-K., & Jin, W. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac024 · Cited by 44 · cited 1×
“While early-phase trials have shown promising results in terms of safety and short-term efficacy, large-scale, randomized controlled trials are necessary to validate these findings and provide robust data on the long-term effectiveness of MSC therapies [162].”
CRISPR–Cas9 gene editing induced complex on-target outcomes in human cells
Wen, W., & Zhang, X. (2022) · Experimental Hematology · doi:10.1016/j.exphem.2022.03.002 · Cited by 42 · cited 2×
“Additionally, complex on-target outcomes, such as large deletions and gene rearrangements, have been observed and require careful consideration [157].”
Ulpiano, C., da Silva, C. L., & Monteiro, G. A. (2023) · Biomedicines · doi:10.3390/biomedicines11041231 · Cited by 42 · cited 2×
“As nano-sized lipid structures, MSC-EVs facilitate cell–cell communication by transporting bioactive molecules between cells [142].”
Choi, Y., Yoon, D. S., Lee, K.-M., Choi, S. M., Lee, M.-H., Park, K. H., Han, S. H., & Lee, J. W. (2019) · Aging and disease · doi:10.14336/ad.2018.0802 · Cited by 41 · cited 1×
“Self-renewal refers to the ability of MSCs to undergo multiple rounds of cell division while maintaining their undifferentiated state, ensuring a sustainable source of stromal cells for therapeutic applications [27].”
Magnetic resonance imaging for non-invasive clinical evaluation of normal and regenerated cartilage
Xu, X., Gao, J., Liu, S., Chen, L., Chen, M., Yu, X., Ma, N., Zhang, J., Chen, X., Zhong, L., et al. (2021) · Regenerative Biomaterials · doi:10.1093/rb/rbab038 · Cited by 41 · cited 2×
“Studies have shown that MRI can effectively evaluate cartilage regeneration and treatment outcomes [187].”
Extracellular Vesicles: a Promising cell-free Therapy for Cartilage Repair
Amsar, R. M., Wijaya, C. H., Ana, I. D., Hidajah, A. C., Notobroto, H. B., Wungu, T. D. K., & Barlian, A. (2021) · Future Science OA · doi:10.2144/fsoa-2021-0096 · Cited by 41 · cited 1×
“Engineering EVs enables the optimization of their cargo to deliver specific therapeutic agents, such as growth factors, anti-inflammatory cytokines, and microRNAs, which promote chondrocyte proliferation and ECM production [135,136].”
Methods and Limitations of Augmenting Mesenchymal Stem Cells for Therapeutic Applications
Huerta, C. T., Ortiz, Y. Y., Liu, Z., & Velazquez, O. C. (2022) · Advances in Wound Care · doi:10.1089/wound.2022.0107 · Cited by 41 · cited 1×
“Other approaches include priming with soluble factors, genetic modifications, and alternative cell delivery systems [224].”
Chen, Y., Yang, L., & Li, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1238972 · Cited by 41 · cited 1×
“They also promote macrophage polarization from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, further mitigating inflammatory responses [42,43].”
Chen, Y., Yu, B., Xue, G., Zhao, J., Li, R., Liu, Z.-L., & Niu, B. (2013) · Cell Transplantation · doi:10.3727/096368912x657602 · Cited by 40 · cited 1×
“Storage solutions significantly affect cell survival, with viability dropping below 70% after 6 h in common parenteral solutions [111].”
Delling, U., Brehm, W., Ludewig, E., Winter, K., & Jülke, H. (2015) · Cell Transplantation · doi:10.3727/096368915x686193 · Cited by 39 · cited 1×
“In sheep and goat models, some studies reported improvements, while others found no significant differences be-tween MSC-treated and control groups [89,90].”
Epigenetic dynamic during endochondral ossification and articular cartilage development
Allas, L., Boumédiene, K., & Baugé, C. (2019) · Bone · doi:10.1016/j.bone.2018.10.004 · Cited by 39 · cited 1×
“Epigenetic factors, including DNA methylation, histone modifications, and non-coding RNAs, play crucial roles in regulating EO and chondrogenesis [121].”
Chang, Y., Wu, K., & Ding, D. (2020) · Stem Cells International · doi:10.1155/2020/8867349 · Cited by 39 · cited 2×
“Overcoming MSC heterogeneity is crucial for standardized production and reliable clinical applications, with strategies such as MSC pooling and iMSC generation showing potential [52,217,219].”
Self-citationWagenbrenner, M., Mayer‐Wagner, S., Rudert, M., Holzapfel, B. M., & Weißenberger, M. (2021) · Gels · doi:10.3390/gels7040217 · Cited by 39 · cited 1×
“Hydrogels, both natural and synthetic, are often combined with MSCs to provide tunable biocompatibility and enhanced cell functionality [202].”
Genetic Comparison of Stemness of Human Umbilical Cord and Dental Pulp
Kang, C., Kim, H. O., Song, J. S., Choi, B.-J., Kim, S., Jung, H.-S., Moon, S. J., & Choi, H.-J. (2016) · Stem Cells International · doi:10.1155/2016/3453890 · Cited by 37 · cited 3×
“CD166 compared to DP, although both sources exhibit similar overall MSC marker expression [37].”
InfluentialLiu, T. P., Ha, P., Xiao, C., Kim, S. Y., Jensen, A. R., Easley, J. T., Yao, Q., & Zhang, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.982199 · Cited by 37 · cited 2×
“Animal models have been instrumental in demonstrating the potential of MSCs for cartilage regeneration [22].”
Todtenhaupt, P., Franken, L., Groene, S. G., van Hoolwerff, M., van der Meeren, L. E., van Klink, J. M. M., Roest, A. A. W., de Bruin, C., Ramos, Y. F., Haak, M. C., et al. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.07.004 · Cited by 37 · cited 2×
“Todtenhaupt et al. developed a robust method for human umbilical cord-derived MSCs, optimizing critical variables and demonstrating consistency across 90 donors [105].”
Kuppa, S. S., Kim, H.-K., Kang, J.-Y., Lee, S.-C., Yang, H.-Y., Sankaranarayanan, J., & Seon, J.-K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512282 · Cited by 36 · cited 1×
“These anti-inflammatory actions help mitigate the chronic inflammation typically associated with OA, thereby protecting cartilage from further degradation and creating a more conducive environment for tissue repair [77,78].”
Engineering extracellular vesicles for ROS scavenging and tissue regeneration
Dayem, A. A., Yan, E., Do, M., Kim, Y., Lee, Y. K., Cho, S., & Kim, D. (2024) · Nano Convergence · doi:10.1186/s40580-024-00430-9 · Cited by 36 · cited 1×
“Engineering EVs enables the optimization of their cargo to deliver specific therapeutic agents, such as growth factors, anti-inflammatory cytokines, and microRNAs, which promote chondrocyte proliferation and ECM production [135,136].”
Kovermann, N. J., Basoli, V., Bella, E. D., Alini, M., Lischer, C. J., Schmal, H., Kubosch, E. J., & Stoddart, M. J. (2019) · Cells · doi:10.3390/cells8060636 · Cited by 35 · cited 1×
“This differentiation process is crucial for cartilage regeneration, as MSCs can be induced to adopt the chondrocyte phenotype under specific conditions, such as exposure to growth factors like transforming growth factor-beta (TGF-β ) and bone morphogenetic proteins (BMPs) [46,47].”
Melatonin, tunneling nanotubes, mesenchymal cells, and tissue regeneration
Luchetti, F., Carloni, S., Nasoni, M. G., Reiter, R. J., & Balduini, W. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.353480 · Cited by 35 · cited 1×
“Melatonin, a pleiotropic molecule, can preserve MSC survival and function by reducing oxidative stress, promoting mitochondrial functionality, and facilitating mitochondrial transfer through tunneling nanotubes [227].”
Regenerative Therapy for Osteoarthritis: A Perspective
Im, G., & Kim, T.-K. (2020) · International Journal of Stem Cells · doi:10.15283/ijsc20069 · Cited by 33 · cited 2×
“To justify the high cost of cell therapy, long-term cell survival and durable structural improvements are essential [195,196].”
Zhao, J., Liang, G., Han, Y., Yang, W., Xu, N., Luo, M., Pan, J., Liu, J., & Zeng, L.-F. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061008 · Cited by 32 · cited 1×
“A meta-analysis revealed that MSCs combined with platelet-rich plasma (PRP) improved pain and joint function in OA patients compared to controls or hyaluronic acid alone [178].”
Harrington, J., Sloan, A. J., & Waddington, R. J. (2014) · Connective Tissue Research · doi:10.3109/03008207.2014.923859 · Cited by 31 · cited 1×
“While DP-derived cells show higher colony-forming e ffi ciency, BM-MSCs have greater expansion success While DP-derived cells show higher colony-forming efficiency, BM-MSCs have greater expansion success and differentiation potential [36]. and di ff erentiation potential [36].”
Ahmed, M., Mehmood, A., Bhatti, F.-U.-R., Khan, S. N., & Riazuddin, S. A. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.07.028 · Cited by 31 · cited 2×
“Similarly, adipose-derived MSCs combined with chondrocytes reduced oxidative stress-induced damage and improved cartilage formation in vitro and in vivo [180].”
Zhao, L., Hu, C., Han, F., Cai, F., Wang, J., & Chen, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01721-8 · Cited by 30 · cited 1×
“Preconditioning methods are being explored to enhance MSC efficacy in kidney transplantation [116].”
Genetics in Cartilage Lesions: Basic Science and Therapy Approaches
Szwedowski, D., Szczepanek, J., Paczesny, Ł., Pękala, P. A., Zabrzyński, J., & Kruczyński, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155430 · Cited by 30 · cited 1×
“By analyzing patient-specific factors, such as the severity of cartilage damage, inflammation levels, and genetic predispositions, treatments can be personalized to enhance efficacy [192].”
A Comparative Study of Canine Mesenchymal Stem Cells Isolated from Different Sources
Humeník, F., Maloveská, M., Hudáková, N., Petroušková, P., Horňáková, Ľ., Domaniža, M., Mudroňová, D., Bodnárová, S., & Cizkova, D. (2022) · Animals · doi:10.3390/ani12121502 · Cited by 30 · cited 1×
“7, 31], while UC-MSCs showed superior proliferation doubling time: 17.7 vs. 21.9 hours) and colony BM: 0.4, AT-0.”
InfluentialN-cadherin mimetic hydrogel enhances MSC chondrogenesis through cell metabolism
Ke, W., Ma, L., Wang, B., Song, Y., Luo, R., Li, G., Liao, Z., Shi, Y., Wang, K., Feng, X., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.07.050 · Cited by 30 · cited 1×
“Notably, N-cadherin mimetic hydrogels have been shown to attenuate hypertrophy and enhance chondrogenesis by regulating cell metabolism, specifically glycolysis and fatty acid oxidation [200].”
Lee, K. A. V., Shim, W., Paik, M., Lee, S. C., Shin, J. Y., Ahn, Y. H., Park, K., Kim, J. H., Choi, S., & Lee, G. (2009) · Cytotherapy · doi:10.3109/14653240902974032 · Cited by 29 · cited 1×
“However, MSC viability decreases rapidly after dissociation from culture dishes [110].”
Samara, O., Jafar, H. D., Hamdan, M. Q., Al-Ta’mari, A., Rahmeh, R., Hourani, B., Mandalawi, N., & Awidi, A. (2022) · Regenerative Medicine · doi:10.2217/rme-2021-0121 · Cited by 27 · cited 1×
“In a study using Wharton’s jelly mesenchymal stromal cells for knee OA, MRI scans demonstrated significant improvements in various parameters, including cartilage loss and bone marrow lesions, correlating with functional improvements [190].”
Servais, S., Baron, F., Lechanteur, C., Seidel, L., Baudoux, É., Briquet, A., Selleslag, D., Maertens, J. A., Poiré, X., Schroyens, W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1106464 · Cited by 27 · cited 1×
“MSCs have shown potential in treating poor graft function following hematopoietic cell transplantation, with improved hematological responses and reduced transfusion requirements [115].”
Meng, F., Zq, Z., Gx, H., Chen, W., Zhang, Z., He, A., & Liao, W. (2016) · European Cells and Materials · doi:10.22203/ecm.v031a06 · Cited by 26 · cited 1×
“A novel scaffold composed of tricalcium phosphate, collagen, and hyaluronate has demonstrated superior chondroinductive properties compared with scaffolds without hyaluronate [124].”
Detela, G., Bain, O., Kim, H., Williams, D., Mason, C., Mathur, A., & Wall, I. B. (2018) · Biotechnology Journal · doi:10.1002/biot.201700085 · Cited by 25 · cited 1×
“Detela et al. characterized growth kinetics of bone marrow-derived MSCs from multiple donors, identifying an operating window between passages 1-3 [221].”
Higuchi, J., Yamagami, R., Matsumoto, T., Terao, T., Inoue, K., Tsuji, S., Maenohara, Y., Matsuzaki, T., Chijimatsu, R., Omata, Y., et al. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.04.003 · Cited by 25 · cited 1×
“Pre-treatment MRI findings, such as cartilage lesions and bone marrow lesions, have been associated with improved clinical outcomes following adipose-derived stem cell therapy [188].”
Touani, F. K., Borie, M., Azzi, F., Trudel, D., Noiseux, N., Sarkissian, S. D., & Lerouge, S. (2021) · Stem Cells International · doi:10.1155/2021/6663467 · Cited by 25 · cited 1×
“Pharmacological preconditioning with celastrol, an antioxidant, significantly increases MSC survival and proangiogenic paracrine function when encapsulated in hydrogels [223].”
The Chondro-Osseous Continuum: Is It Possible to Unlock the Potential Assigned Within?
Javaheri, B., Caetano-Silva, S. P., Kanakis, I., Bou–Gharios, G., & Pitsillides, A. A. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00028 · Cited by 24 · cited 2×
“Recent research challenges the traditional view that hypertrophic chondrocytes undergo apoptosis, suggesting instead that they may transdifferentiate into osteoblasts [119,120].”
Pfeifer, C., Karl, A., Kerschbaum, M., Berner, A., Lang, S., Schupfner, R., Koch, M., Angele, P., Nerlich, M. L., & Mueller, M. B. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc18088 · Cited by 24 · cited 1×
“This differentiation process is crucial for cartilage regeneration, as MSCs can be induced to adopt the chondrocyte phenotype under specific conditions, such as exposure to growth factors like transforming growth factor-beta (TGF-β ) and bone morphogenetic proteins (BMPs) [46,47].”
Yu, L., Yu, Y., Liu, S., & Ge, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.898394 · Cited by 24 · cited 1×
“Additionally, novel delivery systems, such as biodegradable hydrogels, are being developed to overcome rapid biodegradation and clearance of EVs in vivo [144].”
Labarre, K. W., & Zimmermann, G. (2022) · Bone Reports · doi:10.1016/j.bonr.2022.101168 · Cited by 22 · cited 1×
“Additionally, the use of adipose-derived stromal vascular fraction has shown potential in improving knee function and reducing pain, with higher cell numbers (an average of 45 million) correlating with better outcomes [64].”
Wang, P., Zhang, S., Meng, Q., Zhu, P., & Yuan, W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1715 · Cited by 22 · cited 1×
“Ongoing and future large-scale trials will provide critical insights into the durability of MSC-induced cartilage regeneration and help determine their role in managing OA and cartilage injuries [167].”
Sampath, S. J. P., Kotikalapudi, N., & Venkatesan, V. (2021) · Stem Cell Investigation · doi:10.21037/sci-2020-048 · Cited by 21 · cited 1×
“The combination of placental-derived MSCs and stigmasterol demonstrated enhanced cartilage repair and regeneration in a rat OA model [185].”
Infusion of Allogeneic Mesenchymal Stromal Cells After Liver Transplantation: A 5‐Year Follow‐Up
Vandermeulen, M., Mohamed‐Wais, M., Erpicum, P., Delbouille, M., Lechanteur, C., Briquet, A., Maggipinto, G., Jouret, F., Beguin, Y. P., & Detry, O. (2021) · Liver Transplantation · doi:10.1002/lt.26323 · Cited by 21 · cited 2×
“Studies have demonstrated the safety of MSC infusion after liver transplantation [113] and kidney transplantation [114].”
Bhattacharjee, A., & Katti, D. S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00246 · Cited by 20 · cited 1×
“Additionally, gelatin scaffolds with aligned pore architecture have been shown to improve cellular infiltration, alignment, and chondrogenic differentiation of infrapatellar fat pad-derived MSCs compared with those with random pore structures [125].”
Jeyaraman, M., Muthu, S., Nischith, D. S., Jeyaraman, N., Nallakumarasamy, A., & Khanna, M. (2022) · Indian Journal of Orthopaedics · doi:10.1007/s43465-022-00751-z · Cited by 20
Efficient CRISPR-Cas9-based knockdown of RUNX2 to induce chondrogenic differentiation of stem cells
Kim, H. J., Park, J. M., Lee, S., Cho, H. B., Park, J.-I., Kim, J.-H., Park, J. S., & Park, K. (2021) · Biomaterials Science · doi:10.1039/d1bm01716k · Cited by 19 · cited 1×
“Efficient RUNX2 knockdown using CRISPR-Cas9 has been shown to decrease osteogenic differentiation and increase chondrogenic differentiation of MSCs [150].”
Lamo-Espinosa, J. M., Prósper, F., Blanco, J. F., Sanchez-Guijo, F. M., Alberca, M., García, V., González‐Vallinas, M., & Garcı́a-Sancho, J. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03160-2 · Cited by 19 · cited 1×
“Lamo-Espinosa et al. reported that the same beneficial effects of MSC treatment with different cell dosages (10, 40 and 100 million cells) can persist for up to 4 years after a single injection [63].”
Chang, Y., Wu, K., Wang, C., & Ding, D. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36966 · Cited by 18 · cited 2×
“Recent studies have explored the use of biocompatible scaffolds to enhance MSC retention and chondrogenic differentiation [123].”
Self-citationRenesme, L., Cobey, K. D., Lê, M., Lalu, M. M., & Thébaud, B. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-054740 · Cited by 18 · cited 1×
“The update ISCT recommendation includes using the term “mesenchymal stromal cells” for MSCs, reporting tissue of origin, and functional assays to test cells’ properties and potency [29,30].”
Mechanobiological Approaches for Stimulating Chondrogenesis of Stem Cells
Volz, M., Wyse‐Sookoo, K., Travascio, F., Huang, C.-Y. C., & Best, T. M. (2022) · Stem Cells and Development · doi:10.1089/scd.2022.0049 · Cited by 18 · cited 1×
“Mechanobiological stimulation of stem cells has also been investigated to recreate specific environmental conditions for chondrogenesis [201].”
Huang, S. ‐., Liu, Y., Wang, C., Xiang, W., Wang, N., Peng, L., Jiang, X., Zhang, X., & Fu, Z. (2023) · Orthopaedic Surgery · doi:10.1111/os.13848 · Cited by 18 · cited 1×
“Additionally, exploring the use of MSC-derived products, such as EVs or engineered scaffolds, may offer alternative or complementary strategies for cartilage repair [164,165].”
Lee, H. J., Chae, C. W., & Han, H. J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115759 · Cited by 18 · cited 1×
“Mitochondrial dysfunction, a primary cause of MSC death and senescence, is exacerbated in hyperglycemic conditions [226].”
Wright, A., Snyder, L., Knights, K., Hong Bin, H. E., Springer, N. L., Lillich, J. D., & Weiss, M. L. (2020) · Stem Cells and Development · doi:10.1089/scd.2019.0145 · Cited by 17 · cited 1×
“Wright et al. optimized protocols for canine umbilical cord-derived MSCs, addressing the challenge of maintaining these cells in culture for extended periods [108].”
Emerging Concepts of Endotypes/Phenotypes in Regenerative Medicine for Osteoarthritis
Im, G., & Moon, J.-Y. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00397-2 · Cited by 17 · cited 2×
“The concept of endotypes and phenotypes in OA helps explain variations in clinical manifestations, etiology, and pathophysiology, potentially improving patient selection for regenerative therapies [194].”
Implication of Mesenchymal Stem Cells and Their Derivates for Osteochondral Regeneration
Smolinská, V., Debreova, M., Culenova, M., Csöbönyeiová, M., Švec, A., & Danišovič, Ľ. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052490 · Cited by 17 · cited 1×
“These engineered vesicles provide a cell-free, minimally invasive alternative to traditional MSC therapies, avoiding potential complications associated with cell transplantation while retaining regenerative benefits [138].”
Extracellular vesicles derived from mesenchymal stem cells: A platform that can be engineered.
Qin, B., Zhāng, Q., Chen, D., Yu, H., Luo, A.-X., Suo, L. P., Cai, Y., Cai, D., Luo, J., Huang, J., et al. (2021) · PubMed · doi:10.14670/hh-18-297 · Cited by 16 · cited 2×
“However, challenges, such as low production, poor retention, and limited targeting, hinder their clinical application [143].”
Functionalized Hydrogels for Cartilage Repair: The Value of Secretome-Instructive Signaling
Barisón, M. J., Nogoceke, R., Josino, R., Horinouchi, C. D. D. S., Marcon, B. H., Correa, A., Stimamiglio, M. A., & Robert, A. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116010 · Cited by 16 · cited 2×
“Combining these delivery systems with MSCs or their derivatives holds great potential for maximizing regenerative outcomes and improving clinical results in cartilage repair therapies. tissue repair over time [175].”
Regenerative medicine for early osteoarthritis
Im, G., & Henrotin, Y. E. (2023) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x231194813 · Cited by 16 · cited 1×
“To justify the high cost of cell therapy, long-term cell survival and durable structural improvements are essential [195,196].”
Mautner, K., Carr, D., Whitley, J., & Bowers, R. L. (2019) · Techniques in Orthopaedics · doi:10.1097/bto.0000000000000357 · Cited by 15 · cited 2×
“However, allogeneic MSCs provide logistical advantages and consistent product quality [60].”
Cited by
Mesenchymal stem cell-derived exosomes: A paradigm shift in clinical therapeutics
Chattopadhyay, S., Rajendran, R. L., Chatterjee, G., Reyaz, D., Prakash, K., Hong, C. M., Ahn, B., ArulJothi, K. N., & Gangadaran, P. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114616 · Cited by 31
Goulian, A. J., Goldstein, B., & Saad, M. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062061 · Cited by 25
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
Nonaka, T., Murata, D., Yoshizato, H., Kashimoto, S., Nakamura, A., Morimoto, T., & Nakayama, K. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05604-7 · Cited by 16
“Therefore, cartilage constructs with an appropriate thickness are difficult to fabricate [24].”
The role of synovial mesenchymal stem cell-derived exosomes in cartilage repair: a systematic review
Su, J., Qi, Y., Niu, L., Wang, Y., Wei, B., Ma, B., Kong, K., Zhai, Z., & Xu, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1617874 · Cited by 13
“Irreversible changes in knee joint structure: exosomes are unable to directly repair osteophytes or reconstruct severely worn cartilage layers, but may reduce pain and in fl ammation by regulating the remaining subchondral bone to talk to the synovium (Wu et al., 2024).”
Coleman, L. J., Byrne, J. L., Edwards, S., & O’Hara, R. (2025) · Biologics · doi:10.3390/biologics5030027 · Cited by 15
“More recent advances include hydrogels, gene therapy, and stem cell-based approaches show promise, particularly mesenchymal stromal cells for their regenerative and anti-inflammatory properties, though delivery, safety, and scalability challenges persist [54,55].”
Metadata
- Authors
- Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z.
- Affiliations
- Tzu Chi University (TW)
- Corresponding author
- Ding, Dah-Ching
- Lin, Shinn-Zong
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-11-30
- Volume
- 25
- Issue
- 23
- Pages
- 12911
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC11641625
- OpenAlex
- W4404903366
- Cited by
- 33
- References
- 228
- Citations by year
- 2026: 22 · 2025: 11
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- NSTC (113-2314-B-303-024)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Keywords
- mesenchymal stem cells, cartilage regeneration, osteoarthritis, cartilage degeneration, chondrogenic differentiation, growth factor secretion, inflammation modulation, bone marrow-derived MSCs, adipose-derived MSCs, exosomes, tumorigenicity, immune rejection, clinical translation
- MeSH terms
- Aging, Animals, Cartilage, Cartilage, Articular, Cell Differentiation, Humans, Osteoarthritis, Regeneration, Chondrocytes, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.